• email
  • rss
  • twitter
  • facebook
  • linkedin
  • News
  • Investors
  • Contact

Ceapro Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Quality Management System
    • Sustainability
  • Technologies
    • Overview
    • Ethanol Fractionation Processes
    • Pressurized Gas Expanded (PGX) Technology
    • Chromatography Purification
    • Intellectual Property
    • Scientific Publications
  • Pipeline
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
    • Product Brochures
  • Cosmeceuticals
    • Overview
  • Nutraceuticals
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
  • Business Development
    • Overview
    • Partners
  • News
  • Investors
  • Contact
  • Home
  • News
  • Media Coverage
Navigation
  • Press Releases
  • Media Coverage

Media Coverage

Ceapro transitioning to biopharmaceutical company from contract manufacturer

May 7, 2019

Ceapro using patented technology to disrupt the natural health care products sector

May 2, 2019

Ceapro to begin clinical trials for beta glucan to treat high cholesterol

April 15, 2019

CEO Interview

January 22, 2019

Ceapro has big plans for oats

October 6, 2016

Alberta's Ceapro a diversification success story

September 28, 2016

Sign up for email ALERTS Be the first to receive news and updates on Ceapro. Sign Up

  • © 2023 Ceapro Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap